GPT Healthcare Limited reported a net profit of ₹1,273.14 lakh for the first quarter ended June 30, 2026, marking a 65.9% year-on-year increase from ₹768.18 lakh in Q1FY26. Revenue from operations grew 17.8% to ₹12,620.43 lakh, up from ₹10,710.86 lakh in the corresponding period of the previous year. EBITDA rose to 242M rupees from 174M rupees in the year-ago period, with the EBITDA margin expanding significantly to 19.16% from 16.21%. The disproportionate growth in profitability compared to top-line expansion signals significant operating leverage within its single-segment healthcare services business in India.

The Board of Directors approved the unaudited standalone financial results during a meeting held on August 3, 2026, in Kolkata. Statutory auditors S.R. Batliboi & Co. LLP issued an unmodified limited review conclusion on the results pursuant to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Since the company has no subsidiaries or associates, consolidated financial results were not required.

Financial Performance Highlights

The following table summarises the key financial metrics for the quarter:

Total income rose 18.0% to ₹12,823.04 lakh, supported by a 29.6% increase in other income to ₹202.61 lakh. Total expenses increased by a slower 13.8% to ₹11,106.57 lakh, allowing profit before tax to surge 54.5% to ₹1,716.47 lakh. Earnings per share (basic and diluted) stood at ₹1.55 for the quarter, compared to ₹0.94 in Q1FY26.

Cost Structure and Taxation

Employee benefits expense rose 13.8% to ₹2,323.69 lakh, while cost of materials consumed increased 16.8% to ₹2,414.86 lakh. Finance costs saw a modest rise to ₹216.27 lakh from ₹163.28 lakh in the prior year. Depreciation and amortisation expense was ₹688.09 lakh, and other expenses totaled ₹5,463.66 lakh. Total tax expenses amounted to ₹443.33 lakh, comprising current tax of ₹471.00 lakh and a deferred tax credit of ₹27.67 lakh.

What the Numbers Show

The divergence between revenue growth (17.8%) and net profit growth (65.9%) highlights strong margin expansion, further reinforced by the EBITDA margin widening to 19.16% from 16.21% year-on-year. While key input costs such as materials and labor increased, they did so at a rate lower than revenue generation. This efficiency is particularly notable given the company's focus on a single reportable segment—healthcare services in India—suggesting effective pricing power or volume optimization in its service delivery model.

GPT Healthcare Limited will host an earnings call on August 4, 2026, to discuss its un-audited financial results for the first quarter ended June 30, 2026. The conference, scheduled for 11:00 AM IST, provides investors and analysts with an opportunity to review the company's performance in Q1FY27. This disclosure is made in compliance with Regulation 30 read with Part A of Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

The event will be conducted via a conference bridge, allowing participation from both domestic and international stakeholders. Pre-registration is advised to avoid wait times during the session. The company has provided multiple dial-in options to facilitate global access.

Conference Details

The earnings call will feature senior management discussing the financial outcomes of the quarter. Below are the key logistical details for the event:

Management Participants

The following executives will participate in the discussion:

• Atul Tantia, Group CFO
• Anurag Tantia, Executive Director
• Kriti Tantia, CFO

The notice was issued by Ankur Sharma, Company Secretary and Compliance Officer, on July 25, 2026. Investors interested in attending are requested to pre-register through the provided link to ensure smooth access to the conference line.